AI Image
Iovance, A Top 1% Biotech Stock, Crashes In A Surprise Lung Cancer Twist
Investor's Business Daily • • business
Key Points:
- Investor’s Business Daily (IBD) provides information solely for educational and informational purposes and does not offer investment advice or recommendations.
- The data presented is sourced from what IBD believes to be reliable, but no guarantees are made regarding its accuracy, timeliness, or suitability.
- Past investment performance shared by IBD is not indicative of future results, and authors may hold positions in the stocks they discuss.
- Real-time price data comes from Nasdaq Last Sale, but not all market trades are included; ownership and estimate data are provided by LSEG and FactSet respectively.
- IBD and related trademarks are owned by Investor’s Business Daily, LLC, with all rights reserved.
